Aemetis (AMTX) 10-Q 2 Aug 24 2024 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Jul. 31, 2024
Document Information [Line Items]
Entity Central Index Key	0000738214
Entity Registrant Name	AEMETIS, INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-36475
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1407544
Entity Address, Address Line One	20400 Stevens Creek Blvd., Suite 700
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	213-0940
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	AMTX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		47,196,649

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 234	$ 2,667
Accounts receivable	8,764	8,633
Inventories	10,244	18,291
Prepaid expenses	2,265	3,347
Other current assets	2,348	3,462
Total current assets	23,855	36,400
Property, plant and equipment, net	194,042	195,108
Operating lease right-of-use assets	2,195	2,056
Other assets	11,996	9,842
Total assets	232,088	243,406
Current liabilities:
Accounts payable	28,769	32,132
Current portion of long term debt	55,766	13,585
Short term borrowings	18,822	23,443
Other current liabilities	17,496	15,229
Total current liabilities	120,853	84,389
Long term liabilities:
Senior secured notes and revolving notes	157,102	176,476
EB-5 notes	25,500	29,500
Other long term debt	51,826	51,717
Other long term liabilities	5,241	5,112
Total long term liabilities	360,187	375,994
Stockholders' deficit:
Common stock, $0.001 par value; 80,000 authorized; 45,782 and 40,966 shares issued and outstanding each period, respectively	46	41
Additional paid-in capital	285,519	264,058
Accumulated deficit	(528,810)	(475,405)
Accumulated other comprehensive loss	(5,707)	(5,671)
Total stockholders' deficit	(248,952)	(216,977)
Total liabilities and stockholders' deficit	232,088	243,406
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Long term liabilities:
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 120,518	$ 113,189

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Cash and cash equivalents	$ 234	$ 2,667
Accounts receivable	8,764	8,633
Prepaid expenses	2,265	3,347
Other current assets	2,348	3,462
Property, plant and equipment, net	194,042	195,108
Operating lease right-of-use assets	2,195	2,056
Other assets	11,996	9,842
Accounts payable	28,769	32,132
Current portion of long term debt	55,766	13,585
Short term borrowings	18,822	23,443
Other current liabilities	17,496	15,229
Other long term debt	51,826	51,717
Other long term liabilities	$ 5,241	$ 5,112
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized (in shares)	80,000	80,000
Common Stock, Shares Issued (in shares)	45,782	40,966
Common Stock, Shares Outstanding (in shares)	45,782	40,966
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 120,518	$ 113,189
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	0	1,093
Accounts receivable	59	55
Prepaid expenses	600	1,438
Other current assets	55	289
Property, plant and equipment, net	89,566	81,966
Operating lease right-of-use assets	458	145
Other assets	6,031	4,881
Accounts payable	4,905	3,815
Current portion of long term debt	440	190
Short term borrowings	9	9
Other current liabilities	817	48
Other long term debt	44,692	40,857
Other long term liabilities	286	67
Variable Interest Entity, Primary Beneficiary [Member] | Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 120,518	$ 113,189

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations and Comprehensive (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues	$ 66,561	$ 45,112	$ 139,195	$ 47,263
Cost of goods sold	68,367	43,156	141,613	46,602
Gross (loss) profit	(1,806)	1,956	(2,418)	661
Selling, general and administrative	11,800	9,746	20,650	20,574
Operating loss	(13,606)	(7,790)	(23,068)	(19,913)
Interest expense
Interest rate expense	9,904	8,299	18,996	15,377
Debt related fees and amortization expense	1,820	1,330	3,241	3,299
Accretion and other expenses of Series A preferred units	3,477	6,885	6,788	12,449
Other (income) expense	(18)	(91)	49	(167)
Loss before income taxes	(28,789)	(24,213)	(52,142)	(50,871)
Income tax expense	385	1,066	1,263	818
Net loss	(29,174)	(25,279)	(53,405)	(51,689)
Other comprehensive income (loss)
Foreign currency translation (loss) income	8	16	(36)	133
Comprehensive loss	$ (29,166)	$ (25,263)	$ (53,441)	$ (51,556)
Net loss per common share
Basic (in dollars per share)	$ 0.66	$ (0.68)	$ (1.24)	$ (1.4)
Diluted (in dollars per share)	$ 0.66	$ (0.68)	$ (1.24)	$ (1.4)
Weighted average shares outstanding
Basic (in shares)	44,417	37,179	43,153	36,804
Diluted (in shares)	44,417	37,179	43,153	36,804

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net loss	$ (53,405)	$ (51,689)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation	4,946	4,417
Depreciation	3,847	3,461
Debt related fees and amortization expense	3,241	3,289
Intangibles and other amortization expense	24	23
Accretion and other expenses of Series A preferred units	6,788	12,449
Loss on asset disposals	3,644	0
Warrants issued for working capital agreement	0	409
Deferred tax expense	0	701
Changes in operating assets and liabilities:
Accounts receivable	(145)	(4,884)
Inventories	8,028	(2,872)
Prepaid expenses	1,082	2,431
Other assets	(1,318)	0
Accounts payable	(5,961)	4,365
Accrued interest expense and fees	12,614	12,095
Other liabilities	1,243	1,828
Net cash used in operating activities	(15,372)	(13,977)
Investing activities:
Capital expenditures	(8,980)	(9,808)
Grant proceeds and other reimbursements received for capital expenditures	3,045	7,302
Net cash used in investing activities	(5,935)	(2,506)
Financing activities:
Proceeds from borrowings	8,436	21,627
Repayments of borrowings	(4,015)	(13,424)
Lender debt renewal and waiver fee payments	(1,444)	(1,681)
Payments on finance leases	(161)	(311)
Proceeds from sales of common stock	15,891	8,915
Proceeds from exercise of stock options	36	38
Net cash provided by financing activities	18,743	15,164
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	26	(214)
Net change in cash, cash equivalents, and restricted cash for period	(2,538)	(1,533)
Cash, cash equivalents, and restricted cash at beginning of period	6,280	6,999
Cash, cash equivalents and restricted cash at end of period	3,742	5,466
Supplemental disclosures of cash flow information, cash paid:
Cash paid for interest	5,074	4,546
Income taxes paid	878	20
Supplemental disclosures of cash flow information, non-cash transactions:
Subordinated debt extension fees added to debt	340	340
Debt fees added to revolving lines	0	2,236
Fair value of warrants issued to subordinated debt holders	593	448
Fair value of warrants issued to lender for debt issuance costs	0	245
Lender debt extension, waiver, and other fees added to debt	595	384
Cumulative capital expenditures in accounts payable, including net increase of $3,459 and $474, respectively	$ 11,360	$ 15,885

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance	$ 1	$ 36	$ 232,546	$ (428,985)	$ (5,452)	$ (201,854)
Balance (in shares) at Dec. 31, 2022	1,270	35,869
Balance at Dec. 31, 2022	$ 1	$ 36	232,546	(428,985)	(5,452)	(201,854)
Issuance of common stock (in shares)	0	668
Issuance of common stock	$ 0	$ 1	2,616	0	0	2,617
Stock options exercised (in shares)	0	40
Stock options exercised	$ 0	$ 0	0	0	0	0
Stock-based compensation	$ 0	$ 0	2,662	0	0	2,662
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	448	0	0	448
Foreign currency translation (loss) income	0	0	0	0	117	117
Net loss	0	0	0	(26,410)	0	(26,410)
Stock-based compensation	0	0	2,662	0	0	2,662
Foreign currency translation gain	$ 0	$ 0	0	0	117	117
Balance (in shares) at Mar. 31, 2023	1,270	36,690
Balance at Mar. 31, 2023	$ 1	$ 37	238,272	(455,395)	(5,335)	(222,420)
Balance (in shares) at Dec. 31, 2022	1,270	35,869
Balance at Dec. 31, 2022	$ 1	$ 36	232,546	(428,985)	(5,452)	(201,854)
Foreign currency translation (loss) income						133
Net loss						(51,689)
Foreign currency translation gain						133
Balance (in shares) at Jun. 30, 2023	1,260	38,178
Balance at Jun. 30, 2023	$ 1	$ 38	247,017	(480,674)	(5,319)	(238,937)
Balance	$ 1	$ 37	238,272	(455,395)	(5,335)	(222,420)
Balance (in shares) at Mar. 31, 2023	1,270	36,690
Balance at Mar. 31, 2023	$ 1	$ 37	238,272	(455,395)	(5,335)	(222,420)
Issuance of common stock (in shares)	0	1,353
Issuance of common stock	$ 0	$ 1	6,298	0	0	6,299
Stock options exercised (in shares)	0	72
Stock options exercised	$ 0	$ 0	38	0	0	38
Stock-based compensation	$ 0	$ 0	1,755	0	0	1,755
Issuance and exercise of warrants (in shares)	0	62
Issuance and exercise of warrants	$ 0	$ 0	654	0	0	654
Foreign currency translation (loss) income	0	0	0	0	16	16
Net loss	0	0	0	(25,279)	0	(25,279)
Stock-based compensation	0	0	1,755	0	0	1,755
Foreign currency translation gain	$ 0	$ 0	0	0	16	16
Balance (in shares) at Jun. 30, 2023	1,260	38,178
Balance at Jun. 30, 2023	$ 1	$ 38	247,017	(480,674)	(5,319)	(238,937)
Series B conversion to common stock (in shares)	(10)	1
Series B conversion to common stock	$ 0	$ 0	0	0	0	0
Balance	$ 1	38	247,017	(480,674)	(5,319)	(238,937)
Balance		$ 41	264,058	(475,405)	(5,671)	(216,977)
Balance (in shares) at Dec. 31, 2023		40,966
Balance at Dec. 31, 2023		$ 41	264,058	(475,405)	(5,671)	(216,977)
Issuance of common stock (in shares)		1,523
Issuance of common stock		$ 2	5,511	0	0	5,513
Stock options exercised (in shares)		14
Stock options exercised		$ 0	36	0	0	36
Stock-based compensation		$ 0	2,969	0	0	2,969
Issuance and exercise of warrants (in shares)		113
Issuance and exercise of warrants		$ 0	593	0	0	593
Foreign currency translation (loss) income		0	0	0	(44)	(44)
Net loss		0	0	(24,231)	0	(24,231)
Stock-based compensation		0	2,969	0	0	2,969
Foreign currency translation gain		$ 0	0	0	(44)	(44)
Balance (in shares) at Mar. 31, 2024		42,616
Balance at Mar. 31, 2024		$ 43	273,167	(499,636)	(5,715)	(232,141)
Balance (in shares) at Dec. 31, 2023		40,966
Balance at Dec. 31, 2023		$ 41	264,058	(475,405)	(5,671)	(216,977)
Foreign currency translation (loss) income						(36)
Net loss						(53,405)
Foreign currency translation gain						(36)
Balance (in shares) at Jun. 30, 2024		45,782
Balance at Jun. 30, 2024		$ 46	285,519	(528,810)	(5,707)	(248,952)
Balance		$ 43	273,167	(499,636)	(5,715)	(232,141)
Balance (in shares) at Mar. 31, 2024		42,616
Balance at Mar. 31, 2024		$ 43	273,167	(499,636)	(5,715)	(232,141)
Issuance of common stock (in shares)		3,166
Issuance of common stock		$ 3	10,375	0	0	10,378
Stock-based compensation		0	1,977	0	0	1,977
Foreign currency translation (loss) income		0	0	0	8	8
Net loss		0	0	(29,174)	0	(29,174)
Stock-based compensation		0	1,977	0	0	1,977
Foreign currency translation gain		$ 0	0	0	8	8
Balance (in shares) at Jun. 30, 2024		45,782
Balance at Jun. 30, 2024		$ 46	285,519	(528,810)	(5,707)	(248,952)
Balance		$ 46	$ 285,519	$ (528,810)	$ (5,707)	$ (248,952)

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	1. General Nature of Activities Founded in 2006 ► California Ethanol 65 ► California Dairy Renewable Natural Gas nine 36 44 24 2024. ► India Biodiesel 60 one In addition, we are actively growing our business by seeking to develop or acquire new facilities, including the following key projects: ► Sustainable Aviation Fuel and Renewable Diesel 90 2023, March 2024, ► Carbon Capture and Underground Sequestration May 2023, 2024 The Company’s current and planned businesses produce renewable fuels and reduce carbon emissions, while generating valuable Renewable Fuel Standard credits, California Low Carbon Fuel Standard credits, and federal tax credits. Basis of Presentation and Consolidation These consolidated financial statements include the accounts of Aemetis, Inc. and its subsidiaries. We consolidate all entities in which we have a controlling financial interest. A controlling financial interest is usually obtained through ownership of a majority of the voting interests. However, an enterprise must consolidate a variable interest entity (“VIE”) if the enterprise is the primary beneficiary of the VIE, even if the enterprise does not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of June 30, 2024 three six June 30, 2024 2023 six June 30, 2024 2023 three six June 30, 2024 2023 December 31, 2023 2023 The consolidated condensed financial statements in this report should be read in conjunction with the 2023 10 December 31, 2023 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three six June 30, 2024 2023 December 31, 2023 three six June 30, 2024 not There have been no 1 10 December 31, 2023.

Note 2 - Revenue

Note 2 - Revenue	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	2. We derive revenue primarily from sales of ethanol and related co-products in California, renewable natural gas ("RNG") and related environmental attributes in California, and biodiesel and refined glycerin in India. California Ethanol Revenues: second 2023, Given the similarity of the individual sales transactions with J.D. Heiskell, we have assessed them as a portfolio of similar contracts. Prior to May 25, 2023, May 25, 2023, one The following table shows sales in our California Ethanol segment by product category: For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 Ethanol sales $ 29,437 $ 8,647 $ 54,823 $ 9,015 Wet distiller's grains sales 9,302 2,553 18,516 2,553 Other sales 1,393 132 2,882 239 Total $ 40,132 $ 11,332 $ 76,221 $ 11,807 From December 2022 May 2023, June 30, 2023. California Dairy Renewable Natural Gas Revenues: June 30, 2024 nine 36 "D3 D3 third 2023 first 2024. D3 For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 RNG, LCFS and D3 RIN sales $ 1,598 $ 210 $ 5,390 $ 416 India Biodiesel Revenues: The following table shows our sales in our India Biodiesel segment by product category: For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 Biodiesel sales $ 23,708 $ 32,811 $ 54,700 $ 34,001 Other sales 1,123 759 2,884 1,039 Total $ 24,831 $ 33,570 $ 57,584 $ 35,040

Note 3 - Cash and Cash Equivale

Note 3 - Cash and Cash Equivalents	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	3. The following table reconciles cash, cash equivalents, and restricted cash reported in the Consolidated Balance Sheet to the statement of cash flows: As of June 30, 2024 December 31, 2023 Cash and cash equivalents $ 234 $ 2,667 Restricted cash included in other current assets 635 289 Restricted cash included in other assets 2,873 3,324 Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 3,742 $ 6,280 Restricted cash shown in the table above includes amounts required to be set aside by the Aemetis Biogas 1 2

Note 4 - Basic and Diluted Net

Note 4 - Basic and Diluted Net Loss Per Share	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	4. Basic net loss per share is computed by dividing income or loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss per share reflects the dilution of common stock equivalents such as options, convertible preferred stock, debt and warrants to the extent the impact is dilutive. The following table shows the number of potentially dilutive shares excluded from the diluted net loss per share calculation as of June 30, 2024 2023 As of June 30, 2024 June 30, 2023 Series B preferred (post split basis) - 126 Common stock options and warrants 7,731 6,107 Debt with conversion feature at $30 per share of common stock 1,277 1,251 Total number of potentially dilutive shares 9,008 7,484

Note 5 - Inventories

Note 5 - Inventories	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	5. Inventories Inventories consist of the following: As of June 30, 2024 December 31, 2023 Raw materials $ 4,426 $ 9,907 Work-in-progress 1,788 1,682 Finished goods 4,030 6,702 Total inventories $ 10,244 $ 18,291 As of June 30, 2024 , and December 31, 2023 , the Company recognized a lower of cost or net realizable value adjustment of $0 thousand, respectively, related to inventory.

Note 6 - Property, Plant and Eq

Note 6 - Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	6. Property, Plant and Equipment Property, plant and equipment consist of the following: As of June 30, 2024 December 31, 2023 Land $ 7,345 $ 7,345 Plant and buildings 170,215 136,318 Furniture and fixtures 2,628 2,266 Machinery and equipment 5,628 14,982 Construction in progress 50,538 73,057 Property held for development 15,431 15,431 Finance lease right of use assets 2,889 2,889 Total gross property, plant & equipment 254,674 252,288 Less accumulated depreciation (60,632 ) (57,180 ) Total net property, plant & equipment $ 194,042 $ 195,108 For the three June 30, 2024 2023 not six June 30, 2024 2023 The increase in total gross property, plant and equipment during the six June 30, 2024, one 7 Financing Agreement for Capital Expenditures Construction in progress includes costs for the biogas construction projects (dairy digesters and pipeline), Riverbank projects (sustainable aviation fuel and renewable diesel plant as well as carbon capture characterization well), and energy efficiency projects at the Keyes Plant. Property held for development is the partially completed Goodland Plant which is not Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5 For the three June 30, 2024 2023 six June 30, 2024 2023

Note 7 - Debt

Note 7 - Debt	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	7. Debt Debt consists of the following: June 30, 2024 December 31, 2023 Third Eye Capital term notes $ 7,156 $ 7,159 Third Eye Capital revolving credit facility 26,677 20,922 Third Eye Capital revolving notes Series B 60,976 54,412 Third Eye Capital revenue participation term notes 12,024 12,011 Third Eye Capital acquisition term notes 26,672 26,655 Third Eye Capital Fuels Revolving Line 37,376 32,511 Third Eye Capital Carbon Revolving Line 24,381 23,486 Construction and term loans 45,115 41,024 Cilion shareholder purchase obligation 7,134 7,028 Subordinated notes 18,497 17,625 EB-5 promissory notes 42,665 42,211 Working capital loans 316 3,827 Term loans on capital expenditures 27 5,850 Total debt 309,016 294,721 Less current portion of debt 74,588 37,028 Total long term debt $ 234,428 $ 257,693 Third Eye Capital Note Purchase Agreement On July 6, 2012, A. Term Notes. As of June 30, 2024 , the Company had $7.2 million in principal and interest outstanding under the Term Notes and $81 thousand unamortized debt issuance costs. The Term Notes accrue interest at 14% per annum. The Term Notes mature on April 1, 2025. B. Revolving Credit Facility . The Revolving Credit Facility accrues interest at the prime rate plus 13.75% (22.25% as of June 30, 2024 ) payable monthly in arrears. The Revolving Credit Facility matures on April 1, 2025. June 30, 2024 , AAFK had $27.5 million in principal and interest and waiver fees outstanding and $0.8 million unamortized debt issuance costs under the Revolving Credit Facility. C. Revolving Notes Series B . The Revolving Notes Series B accrues interest at the prime rate plus 13.75% (22.25% as of June 30, 2024 ) payable monthly in arrears. The Revolving Notes Series B matures on April 1, 2025. June 30, 2024 , AAFK had $61.6 million in principal and interest and waiver fees outstanding and $0.6 million unamortized debt issuance costs under the Revolving Notes Series B. D. Revenue Participation Term Notes . The Revenue Participation Term Notes bear interest at 5% per annum and mature on April 1, 2025. June 30, 2024 , AAFK had $12.2 million in principal and interest outstanding under the Revenue Participation Term Notes and $128 thousand unamortized debt issuance costs. E. Acquisition Term Notes . The Acquisition Term Notes accrue interest at the prime rate plus 10.75% (19.25% per annum as of June 30, 2024 ) and mature on April 1, 2025. June 30, 2024 , Aemetis Facility Keyes, Inc. had $26.9 million in principal and interest and redemption fees outstanding under the Acquisition Term Notes and $255 thousand unamortized debt issuance costs. The outstanding principal balance includes $7.5 million in redemption fee on which interest is not The maturity dates on each of the above notes can be extended by the Company from April 1, 2025, April 1, 2026, The Original Third Eye Capital Notes contain various covenants, including but not not twelve first Third Eye Capital Reserve Facility. March 6, 2020, March 25, 2024, April 1, 2025. may may As of June 30, 2024 , we have no Third Eye Capital Revolving Credit Facility for Fuels and Carbon Lines. March 2, 2022, two March 1, 2025, ten March 1, 2026 eight poses and loans made under the Carbon Revolving Line are available for projects that reduce, capture, use, or sequester carbon with the objective of reducing carbon dioxide emissions. As of June 30, 2024 , GAFI had principal and interest outstanding of $38.7 million classified as current debt net of $1.3 million unamortized debt issuance costs. As of June 30, 2024 , ACCI had principal and interest outstanding of $0.8 million classified as current debt, $24.9 million classified as long-term debt, and $1.3 million in unamortized debt issuance costs. Cilion Shareholder Purchase Obligation . In connection with the Company’s merger with Cilion, Inc. (“Cilion”), on July 6, 2012, $5.0 million payment obligation o Cilion shareholders as merger compensation subordinated to the senior secured Third Eye Capital Notes. The liability bears interest at 3% per annum and is due and payable after the Third Eye Capital Notes have been paid in full. As of June 30, 2024 , Aemetis Facility Keyes, Inc. had $7.1 million in Subordinated Notes January 6 January 9, 2012, two six December 31, 2024. six two may June 30, 2024 December 31, 2023 $18.5 million and $17.6 million in principal and interes EB- 5 5 March 4, 2011 ( January 19, 2012 July 24, 2012) 5 72 5 2 3%. 5 Advanced BioEnergy, LP received equity investments by foreign investors, and then Advanced BioEnergy used the invested equity to make loans to the Keyes Plant. The EB- 5 February 27, 2019, 5 5 six As of June 30, 2024 and December 31, 2023 , $38.3 million and $37.9 million was outstanding, respectively, on the EB- 5 On October 16, 2016, 5 5 5 5 5 March 2024, 5 5 first 5 As of June 30, 2024 , and December 31, 2023 , $4.4 million and $4.3 million were outstanding on the notes under the EB- 5 India Biodiesel Secure and Unsecured Loans. November 13, 2023, not November 6, 2023, not one June 30, 2024 December 31, 2023, Aemetis Biogas 1 October 4, 2022, "AB1 AB1 1 December 22, 2023, AB1 "AB1 AB1 1 five five January 22, 2024, ( January 22, 2025, December 22, 2042, AB1 2025, AB1 June 30, 2024, December 31, 2023, AB1 Aemetis Biogas 2 July 28, 2023, "AB2 AB2 not 2 five five AB2 August 15, 2023, ( August 15, 2025, July 28, 2043, AB2 2025, AB2 June 30, 2024, December 31, 2023, AB2 Financing Agreement for Capital Expenditures. 2018, TM no June 2024, 2018 Maturity Date Schedule Scheduled debt repayments for the Company’s loan obligations by year are as follows: Twelve Months ended June 30, Debt Repayments 2025 $ 74,588 2026 180,347 2027 11,151 2028 4,232 2029 1,981 Thereafter 40,671 Total debt 312,970 Debt issuance costs (3,954 ) Total debt, net of debt issuance costs $ 309,016

Note 8 - Leases

Note 8 - Leases	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Operating and Finance Leases [Text Block]	8. The Company is a party to operating leases for the Company's corporate office in Cupertino, modular offices at the Keyes Plant and Biogas operations center, and laboratory facilities. We have also entered into several finance leases for mobile equipment and for the Riverbank Industrial Complex. These finance leases have a purchase option at the end of the term that we are reasonably certain we will exercise, so the leases are classified as finance leases. Our leases have remaining terms of one 12 The Company evaluates leases in accordance with ASC 842 Lease Accounting The components of lease expense are as follows: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating lease cost Operating lease expense $ 196 $ 181 $ 377 $ 362 Short term lease expense 42 21 63 42 Variable lease expense 35 22 67 44 Total operating lease cost $ 273 $ 224 $ 507 $ 448 Finance lease cost Amortization of right-of-use assets $ 30 $ 30 $ 60 $ 61 Interest on lease liabilities 83 82 169 173 Total finance lease cost $ 113 $ 112 $ 229 $ 234 Cash paid for amounts included in the measurement of lease liabilities: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating cash flows used in operating leases $ 246 $ 166 $ 414 $ 330 Operating cash flows used in finance leases 83 82 169 173 Financing cash flows used in finance leases $ 154 $ 228 $ 161 $ 311 Supplemental non-cash flow information related to ROU asset and lease liabilities was as follows for the three six June 30, 2024 2023 Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating leases Accretion of the lease liability $ 89 $ 84 $ 164 $ 171 Amortization of right-of-use assets 106 97 211 191 The weighted average remaining lease term and weighted average discount rate as of June 30, 2024 are as follows: Weighted Average Remaining Lease Term Operating leases (in years) 6.5 4.7 Finance leases (in years) 12.6 13.5 Weighted Average Discount Rate Operating leases 13.7 % 14.1 % Finance leases 13.3 % 13.2 % Supplemental balance sheet information related to leases is as follows: June 30, 2024 December 31, 2023 Operating leases Operating lease right-of-use assets $ 2,195 $ 2,056 Other current liability 475 406 Other long term liabilities 1,813 1,783 Total operating lease liabilities 2,288 2,189 Finance leases Property and equipment, at cost $ 2,889 $ 2,889 Accumulated depreciation (288 ) (228 ) Property and equipment, net 2,601 2,661 Other current liability 32 30 Other long term liabilities 2,692 2,687 Total finance lease liabilities 2,724 2,717 Maturities of operating lease liabilities are as follows: Twelve months ended June 30, Operating leases Finance leases 2025 $ 787 $ 179 2026 721 151 2027 698 145 2028 661 145 2029 63 145 Thereafter 1,235 9,960 Total lease payments 4,165 10,725 Less imputed interest (1,877 ) (8,001 ) Total lease liability $ 2,288 $ 2,724 The Company acts as sublessor in certain leasing arrangements, primarily related to land and buildings. Fixed sublease payments received are recognized on a straight-line basis over the sublease term. Sublease income and head lease expense for these transactions are recognized on net basis on the consolidated financial statements. Sublease income is recorded in the other operating income section of the Consolidated Statements of Operations and Comprehensive Loss. The components of lease income are as follows for the six June 30, 2024 2023, Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Lease income $ 516 $ 484 $ 1,007 $ 953 Future lease commitments to be received by the Company as of June 30, 2024 Twelve months ended June 30, 2025 $ 891 2026 805 2027 672 2028 599 2029 617 Thereafter 474 Total future lease commitments $ 4,058

Note 9 - Aemetis Biogas LLC - S

Note 9 - Aemetis Biogas LLC - Series A Preferred Financing	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Variable Interest Entity Disclosure [Text Block]	9. Series A Preferred Financing On December 20, 2018, X 2022, ABGL has entered into an agreement entitled Sixth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (“PUPA Sixth Amendment") with an Effective Date of April 30, 2024, August 31, 2024, not X September 1, 2024 August 31, 2025, ASC 470 60 no The Company recorded Series A Preferred Unit liabilities of $120.5 million and $113.2 million as long term liabilities as of June 30, 2024 , and December 31, 2023 , respectively.

Note 10 - Stock-based Compensat

Note 10 - Stock-based Compensation	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	10. 2019 On August 26, 2021, 2019 “2019 not three June 30, 2024. 2019 six June 30, 2024 Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2023 456 5,526 $ 4.42 Authorized 1,740 - - Options Granted (1,761 ) 1,761 3.10 RSAs Granted (364 ) - - Exercised - (15 ) 2.56 Forfeited/expired 71 (71 ) 7.39 Balance as of June 30, 2024 142 7,201 $ 4.07 The number of outstanding option shares as of June 30, 2024 vested. Inducement Equity Plan In March 2016, not June 30, 2024 no Stock-based Compensation Expense Stock-based compensation is accounted for in accordance with ASC 718, 14, Share-Based Payment not zero The weighted average fair value calculations for the options granted during the six June 30, 2024 2023 For the six months ended June 30, Description 2024 2023 Dividend-yield - - Risk-free interest rate 4.08 % 3.82 % Expected volatility 115.42 % 125.32 % Expected life (years) 5.81 7.00 Market value per share on grant date $ 3.10 $ 3.75 Fair value per option on grant date $ 2.65 $ 3.43 During the six June 30, 2024 2023, As of June 30, 2024 ha June 30, 2024

Note 11 - Warrants

Note 11 - Warrants	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Outstanding Warrants [Text Block]	11. During the three June 30, 2024 no six June 30, 2024 Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2023 530 $ 11.70 5.77 Granted 113 0.01 Exercised (113 ) 0.01 Outstanding June 30, 2024 530 $ 11.70 5.29 All of the above outstanding warrants are fully vested and exercisable as of June 30, 2024 The fair value calculations for issued warrants are based on the following weighted average factors: For the six months ended June 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 4.23 % 3.76 % Expected volatility 101.36 % 121.50 % Expected life (years) 2.00 5.43 Exercise price per share $ 0.01 $ 1.53 Market value per share on grant date $ 5.24 $ 3.14 Fair value per share on grant date $ 5.23 $ 2.95

Note 12 - Agreements

Note 12 - Agreements	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Collaborative Arrangement Disclosure [Text Block]	12. J.D. Heiskell Working Capital Agreements May 2023, The sales and purchases activity associated with the J.D. Heiskell Purchase Agreement and J.D. Heiskell Procurement Agreement during the three six June 30, 2024 2023 As of and for the three months ended June 30, As of and for the six months ended June 30, 2024 2023 2024 2023 Ethanol sales $ 29,437 $ 8,647 $ 54,823 $ 8,647 Wet distiller's grains sales 9,302 2,553 18,516 2,553 Corn oil sales 1,161 89 2,452 125 CDS sales 5 11 26 11 Corn purchases 33,407 11,611 64,320 11,913 June 30, 2024 December 31, 2023 Accounts receivable 1,322 1,073 Accounts payable 1,240 1,207 Ethanol and Wet Distillers Grains Marketing Arrangement. May 30, 2023, No. 1 March 31, 2025. December 31, 2024, one The agreements with J.D. Heiskell, Murex, and A.L. Gilbert include marketing and transportation services. For the three June 30, 2024 2023 , the Company expensed marketing costs of $0.7 million and $0.2 million, respectively, and for the six June 30, 2024 2023, three June 30, 2024, six June 30, 2024, three six June 30, 2023, not Supply Trade Agreement. July 1, 2022, ten June 2025, one June 30, 2024, December 31, 2023, Forward Sale Commitments. June 30, 2024, Natural Gas Purchase Agreement. June 30, 2024, 394 July October 2024, normal purchases and normal sales scope exception under ASC 815,

Note 13 - Segment Information

Note 13 - Segment Information	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	13. Segment Information Aemetis recognizes three ● The “California Ethanol” segment includes the Company’s 65 million gallon per year ethanol plant in Keyes, California, and the adjacent land leased for the production of CO₂. ● The “California Dairy Renewable Natural Gas” segment includes the production and sale of Renewable Natural Gas ("RNG") and associated environmental attributes, consisting of nine 36 ● The “India Biodiesel” segment includes the Company’s 60 million gallon per year nameplate capacity biodiesel manufacturing plant in Kakinada India, and administrative offices in Hyderabad, India. The Company has additional operating segments that have been determined not Summarized financial information by reportable segment for the three June 30, 2024 2023 For the three months ended June 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues $ 40,132 $ 1,598 $ 24,831 $ - $ 66,561 Gross profit (loss) (3,921 ) (136 ) 2,251 - (1,806 ) Interest expense including amortization of debt fees 7,919 730 204 2,871 11,724 Accretion and other expenses of Series A preferred units - 3,477 - - 3,477 Income tax expense - 2 383 - 385 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 323 4,306 14 754 5,397 Depreciation 1,043 771 180 55 2,049 For the three months ended June 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues 11,332 $ 210 $ 33,570 $ - $ 45,112 Gross loss (2,322 ) (1,064 ) 5,342 - 1,956 Interest expense including amortization of debt fees 6,252 517 225 2,635 9,629 Accretion and other expenses of Series A preferred units - 6,885 - - 6,885 Capital expenditures 726 1,304 115 47 2,192 Depreciation 960 523 157 31 1,671 Summarized financial information by reportable segment for the six June 30, 2024 2023 For the six months ended June 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 76,221 $ 5,390 $ 57,584 $ - $ 139,195 Gross profit (loss) (9,579 ) 2,074 5,087 - (2,418 ) Interest expense including amortization of debt fees 14,896 1,366 629 5,346 22,237 Accretion and other expenses of Series A preferred units - 6,788 - - 6,788 Income tax expense - 36 1,227 - 1,263 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 430 7,149 318 1,083 8,980 Depreciation 2,009 1,340 388 110 3,847 For the six months ended June 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 11,807 $ 416 $ 35,040 $ - $ 47,263 Intersegment revenues - - - - - Gross profit (loss) (2,334 ) (1,837 ) 4,832 - 661 Interest expense including amortization of debt fees 11,770 1,221 294 5,391 18,676 Accretion and other expenses of Series A preferred units - 12,449 - - 12,449 Capital expenditures 1,060 7,803 151 794 9,808 Depreciation 2,069 980 312 100 3,461 California Ethanol: Sales of ethanol, WDG, one three June 30, 2024 . Sales of ethanol, WDG, and corn oil to one customer acc e Company’s California Ethanol segment reven three June 30, 2023 Sales of ethanol, WDG, one customer (J.D. Heiskell) accounted for 92.9% of the Company’s California Ethanol segment revenues for the six June 30, 2024 . Sales of ethanol, WDG, and corn oil to one customer (J.D. Heiskell) acc e Company’s California Ethanol segment reven six June 30, 2023 California Dairy Renewable Natural Gas: three six June 30, 2024 D3 two three June 30, 2023 India Biodiesel: three June 30, 2024 three June 30, 2023. six June 30, 2024 three June 30, 2023. . Total assets by reportable segment as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 California Ethanol $ 58,966 $ 67,991 California Dairy Renewable Natural Gas 105,664 92,794 India Biodiesel 26,547 34,769 All Other 40,911 47,852 Total consolidated assets $ 232,088 $ 243,406

Note 14 - Related Party Transac

Note 14 - Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	14. Related Party Transactions The Company owes Eric McAfee, the Company’s Chairman and CEO, and McAfee Capital LLC (“McAfee Capital”), owned by Eric McAfee, $0.9 million in connection with employment agreements, bonus awards, expense reimbursements, and guarantee fees in connection with McAfee Capital’s guarantees of the Company’s indebtedness with Third Eye Capital. The Company owes various members of the Board amounts totaling $0.3 million as of June 30, 2024 , and December 31, 2023 , in connection with board compensation fees, which are included in accounts payable on the balance sheet. For the three June 30, 2024 2023 , the Company expensed $0.1 million respectively, in connection with board compensation fees. For the six June 30, 2024 2023 , the Company expensed $0.2 million respectively, in connection with board compensation fees.

Note 15 - Subsequent Events

Note 15 - Subsequent Events	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	15. Subsequent Events Subordinated Debt On July 1, 2024, two December 31, 2024. two Third Eye Capital Note Extension On July 31, 2024, 29 29" one April 1, 2025, April 1, 2026, 29 10.1 Note 7. Series A Preferred Unit Purchase Agreement On July 31, 2024, August 31, 2024, $113 twelve not 10.2 Note 9.

Note 16 - Liquidity

Note 16 - Liquidity	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	16. The accompanying financial statements have been prepared contemplating the realization of assets and satisfaction of liabilities in the normal course of business. As a result of negative capital, negative operating results, and collateralization of substantially all of the Company assets, the Company has been reliant on its senior secured lender to provide extensions to the maturity dates of its debt and loan facilities and was required in 2023 twelve twelve Operations and Project Development For the Keyes Plant, we plan to operate the plant and continue to improve its financial performance by adopting new technologies or process changes that allow for energy efficiency, cost reduction, or revenue enhancements, as well as execute upon awarded grants that support investments in equipment to improve energy and operational efficiencies resulting in lower cost, lower carbon emissions, and overall margin improvement. For Aemetis Biogas, we plan to operate our existing biogas digesters to produce and sell Renewable Natural Gas (RNG) and the associated Federal D3 2023 2024, For the Kakinada Plant, we plan to continue to sell our biodiesel to OMCs pursuant to cost-plus contracts. We are also continuing to upgrade the plant to increase feedstock flexibility (and thereby lower feedstock costs), increase production capacity, and produce new products. Additionally, we are in the process of negotiating contractual arrangements for the export of refined animal tallow into international markets. Financing We plan to continue to locate funding for existing and new business opportunities through a combination of working with our senior lender, restructuring existing loan agreements, entering into additional debt agreements for specific projects, obtaining project specific equity and debt for development projects, and obtaining additional debt from the current EB- 5

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
	Jun. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	5. Other Current Reports On July 31, 2024, 29 29" 29 10.1 7. 15. On July 31, 2024, 10.2 9. 15.
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Consolidation These consolidated financial statements include the accounts of Aemetis, Inc. and its subsidiaries. We consolidate all entities in which we have a controlling financial interest. A controlling financial interest is usually obtained through ownership of a majority of the voting interests. However, an enterprise must consolidate a variable interest entity (“VIE”) if the enterprise is the primary beneficiary of the VIE, even if the enterprise does not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of June 30, 2024 three six June 30, 2024 2023 six June 30, 2024 2023 three six June 30, 2024 2023 December 31, 2023 2023 The consolidated condensed financial statements in this report should be read in conjunction with the 2023 10 December 31, 2023 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three six June 30, 2024 2023 December 31, 2023 three six June 30, 2024 not There have been no 1 10 December 31, 2023.

Note 2 - Revenue (Tables)

Note 2 - Revenue (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 Ethanol sales $ 29,437 $ 8,647 $ 54,823 $ 9,015 Wet distiller's grains sales 9,302 2,553 18,516 2,553 Other sales 1,393 132 2,882 239 Total $ 40,132 $ 11,332 $ 76,221 $ 11,807 For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 RNG, LCFS and D3 RIN sales $ 1,598 $ 210 $ 5,390 $ 416
Schedule of America by Product Category [Table Text Block]	For the three months ended June 30, For the six months ended June 30, 2024 2023 2024 2023 Biodiesel sales $ 23,708 $ 32,811 $ 54,700 $ 34,001 Other sales 1,123 759 2,884 1,039 Total $ 24,831 $ 33,570 $ 57,584 $ 35,040

Note 3 - Cash and Cash Equiva_2

Note 3 - Cash and Cash Equivalents (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Cash and Cash Equivalents [Table Text Block]	As of June 30, 2024 December 31, 2023 Cash and cash equivalents $ 234 $ 2,667 Restricted cash included in other current assets 635 289 Restricted cash included in other assets 2,873 3,324 Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 3,742 $ 6,280

Note 4 - Basic and Diluted Ne_2

Note 4 - Basic and Diluted Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	As of June 30, 2024 June 30, 2023 Series B preferred (post split basis) - 126 Common stock options and warrants 7,731 6,107 Debt with conversion feature at $30 per share of common stock 1,277 1,251 Total number of potentially dilutive shares 9,008 7,484

Note 5 - Inventories (Tables)

Note 5 - Inventories (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	As of June 30, 2024 December 31, 2023 Raw materials $ 4,426 $ 9,907 Work-in-progress 1,788 1,682 Finished goods 4,030 6,702 Total inventories $ 10,244 $ 18,291

Note 6 - Property, Plant and _2

Note 6 - Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of June 30, 2024 December 31, 2023 Land $ 7,345 $ 7,345 Plant and buildings 170,215 136,318 Furniture and fixtures 2,628 2,266 Machinery and equipment 5,628 14,982 Construction in progress 50,538 73,057 Property held for development 15,431 15,431 Finance lease right of use assets 2,889 2,889 Total gross property, plant & equipment 254,674 252,288 Less accumulated depreciation (60,632 ) (57,180 ) Total net property, plant & equipment $ 194,042 $ 195,108
Depreciation Of Property, Plant, and Equipment [Table Text Block]	Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5

Note 7 - Debt (Tables)

Note 7 - Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Debt [Table Text Block]	June 30, 2024 December 31, 2023 Third Eye Capital term notes $ 7,156 $ 7,159 Third Eye Capital revolving credit facility 26,677 20,922 Third Eye Capital revolving notes Series B 60,976 54,412 Third Eye Capital revenue participation term notes 12,024 12,011 Third Eye Capital acquisition term notes 26,672 26,655 Third Eye Capital Fuels Revolving Line 37,376 32,511 Third Eye Capital Carbon Revolving Line 24,381 23,486 Construction and term loans 45,115 41,024 Cilion shareholder purchase obligation 7,134 7,028 Subordinated notes 18,497 17,625 EB-5 promissory notes 42,665 42,211 Working capital loans 316 3,827 Term loans on capital expenditures 27 5,850 Total debt 309,016 294,721 Less current portion of debt 74,588 37,028 Total long term debt $ 234,428 $ 257,693
Schedule of Maturities of Long-Term Debt [Table Text Block]	Twelve Months ended June 30, Debt Repayments 2025 $ 74,588 2026 180,347 2027 11,151 2028 4,232 2029 1,981 Thereafter 40,671 Total debt 312,970 Debt issuance costs (3,954 ) Total debt, net of debt issuance costs $ 309,016

Note 8 - Leases (Tables)

Note 8 - Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Lease, Cost [Table Text Block]	Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating lease cost Operating lease expense $ 196 $ 181 $ 377 $ 362 Short term lease expense 42 21 63 42 Variable lease expense 35 22 67 44 Total operating lease cost $ 273 $ 224 $ 507 $ 448 Finance lease cost Amortization of right-of-use assets $ 30 $ 30 $ 60 $ 61 Interest on lease liabilities 83 82 169 173 Total finance lease cost $ 113 $ 112 $ 229 $ 234 Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating cash flows used in operating leases $ 246 $ 166 $ 414 $ 330 Operating cash flows used in finance leases 83 82 169 173 Financing cash flows used in finance leases $ 154 $ 228 $ 161 $ 311
Supplemental Non-cash Flow Information Related to Leases [Table Text Block]	Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating leases Accretion of the lease liability $ 89 $ 84 $ 164 $ 171 Amortization of right-of-use assets 106 97 211 191 The weighted average remaining lease term and weighted average discount rate as of June 30, 2024 are as follows: Weighted Average Remaining Lease Term Operating leases (in years) 6.5 4.7 Finance leases (in years) 12.6 13.5 Weighted Average Discount Rate Operating leases 13.7 % 14.1 % Finance leases 13.3 % 13.2 %
Supplemental Balance Sheet Information Related to Leases [Table Text Block]	June 30, 2024 December 31, 2023 Operating leases Operating lease right-of-use assets $ 2,195 $ 2,056 Other current liability 475 406 Other long term liabilities 1,813 1,783 Total operating lease liabilities 2,288 2,189 Finance leases Property and equipment, at cost $ 2,889 $ 2,889 Accumulated depreciation (288 ) (228 ) Property and equipment, net 2,601 2,661 Other current liability 32 30 Other long term liabilities 2,692 2,687 Total finance lease liabilities 2,724 2,717
Lease Term [Table Text Block]	Twelve months ended June 30, Operating leases Finance leases 2025 $ 787 $ 179 2026 721 151 2027 698 145 2028 661 145 2029 63 145 Thereafter 1,235 9,960 Total lease payments 4,165 10,725 Less imputed interest (1,877 ) (8,001 ) Total lease liability $ 2,288 $ 2,724
Operating Lease, Lease Income [Table Text Block]	Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Lease income $ 516 $ 484 $ 1,007 $ 953
Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]	Twelve months ended June 30, 2025 $ 891 2026 805 2027 672 2028 599 2029 617 Thereafter 474 Total future lease commitments $ 4,058

Note 10 - Stock-based Compens_2

Note 10 - Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2023 456 5,526 $ 4.42 Authorized 1,740 - - Options Granted (1,761 ) 1,761 3.10 RSAs Granted (364 ) - - Exercised - (15 ) 2.56 Forfeited/expired 71 (71 ) 7.39 Balance as of June 30, 2024 142 7,201 $ 4.07
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the six months ended June 30, Description 2024 2023 Dividend-yield - - Risk-free interest rate 4.08 % 3.82 % Expected volatility 115.42 % 125.32 % Expected life (years) 5.81 7.00 Market value per share on grant date $ 3.10 $ 3.75 Fair value per option on grant date $ 2.65 $ 3.43

Note 11 - Warrants (Tables)

Note 11 - Warrants (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2023 530 $ 11.70 5.77 Granted 113 0.01 Exercised (113 ) 0.01 Outstanding June 30, 2024 530 $ 11.70 5.29
Schedule of Warrants, Valuation Assumptions [Table Text Block]	For the six months ended June 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 4.23 % 3.76 % Expected volatility 101.36 % 121.50 % Expected life (years) 2.00 5.43 Exercise price per share $ 0.01 $ 1.53 Market value per share on grant date $ 5.24 $ 3.14 Fair value per share on grant date $ 5.23 $ 2.95

Note 12 - Agreements (Tables)

Note 12 - Agreements (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]	As of and for the three months ended June 30, As of and for the six months ended June 30, 2024 2023 2024 2023 Ethanol sales $ 29,437 $ 8,647 $ 54,823 $ 8,647 Wet distiller's grains sales 9,302 2,553 18,516 2,553 Corn oil sales 1,161 89 2,452 125 CDS sales 5 11 26 11 Corn purchases 33,407 11,611 64,320 11,913 June 30, 2024 December 31, 2023 Accounts receivable 1,322 1,073 Accounts payable 1,240 1,207

Note 13 - Segment Information (

Note 13 - Segment Information (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	For the three months ended June 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues $ 40,132 $ 1,598 $ 24,831 $ - $ 66,561 Gross profit (loss) (3,921 ) (136 ) 2,251 - (1,806 ) Interest expense including amortization of debt fees 7,919 730 204 2,871 11,724 Accretion and other expenses of Series A preferred units - 3,477 - - 3,477 Income tax expense - 2 383 - 385 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 323 4,306 14 754 5,397 Depreciation 1,043 771 180 55 2,049 For the three months ended June 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues 11,332 $ 210 $ 33,570 $ - $ 45,112 Gross loss (2,322 ) (1,064 ) 5,342 - 1,956 Interest expense including amortization of debt fees 6,252 517 225 2,635 9,629 Accretion and other expenses of Series A preferred units - 6,885 - - 6,885 Capital expenditures 726 1,304 115 47 2,192 Depreciation 960 523 157 31 1,671 For the six months ended June 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 76,221 $ 5,390 $ 57,584 $ - $ 139,195 Gross profit (loss) (9,579 ) 2,074 5,087 - (2,418 ) Interest expense including amortization of debt fees 14,896 1,366 629 5,346 22,237 Accretion and other expenses of Series A preferred units - 6,788 - - 6,788 Income tax expense - 36 1,227 - 1,263 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 430 7,149 318 1,083 8,980 Depreciation 2,009 1,340 388 110 3,847 For the six months ended June 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues from external customers $ 11,807 $ 416 $ 35,040 $ - $ 47,263 Intersegment revenues - - - - - Gross profit (loss) (2,334 ) (1,837 ) 4,832 - 661 Interest expense including amortization of debt fees 11,770 1,221 294 5,391 18,676 Accretion and other expenses of Series A preferred units - 12,449 - - 12,449 Capital expenditures 1,060 7,803 151 794 9,808 Depreciation 2,069 980 312 100 3,461
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	June 30, 2024 December 31, 2023 California Ethanol $ 58,966 $ 67,991 California Dairy Renewable Natural Gas 105,664 92,794 India Biodiesel 26,547 34,769 All Other 40,911 47,852 Total consolidated assets $ 232,088 $ 243,406

Note 2 - Revenue - Disaggregati

Note 2 - Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
California Ethanol [Member] | Alternative Energy, Ethanol [Member]
Sales	$ 29,437	$ 8,647	$ 54,823	$ 9,015
California Ethanol [Member] | Wet Distillers Grains [Member]
Sales	9,302	2,553	18,516	2,553
California Ethanol [Member] | Product and Service, Other [Member]
Sales	1,393	132	2,882	239
California Dairy Renewable Natural Gas [Member] | Gas Molecules and RIN Credits [Member]
Sales	1,598	210	5,390	416
RNG, LCFS and D3 RIN Sales [Member]
Sales	$ 40,132	$ 11,332	$ 76,221	$ 11,807

Note 2 - Revenue - Schedule Of

Note 2 - Revenue - Schedule Of America By Product Category (Details) - India Biodiesel [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Sales	$ 24,831	$ 33,570	$ 57,584	$ 35,040
Renewable Energy, Biodiesel [Member]
Sales	23,708	32,811	54,700	34,001
Product and Service, Other [Member]
Sales	$ 1,123	$ 759	$ 2,884	$ 1,039

Note 3 - Cash and Cash Equiva_3

Note 3 - Cash and Cash Equivalents - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Cash and cash equivalents	$ 234	$ 2,667
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	3,742	6,280
Other Current Assets [Member]
Restricted cash	635	289
Other Assets [Member]
Restricted cash	$ 2,873	$ 3,324

Note 4 - Basic and Diluted Ne_3

Note 4 - Basic and Diluted Net Loss Per Share - Schedule of Dilutive Securities (Details) - $ / shares shares in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	9,008	7,484
Debt with Conversion Feature [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 30	$ 30
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	1,277	1,251
Series B Convertible Preferred Stock [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	0	126
Common Stock Options and Warrants [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	7,731	6,107

Note 4 - Basic and Diluted Ne_4

Note 4 - Basic and Diluted Net Loss Per Share - Schedule of Dilutive Securities (Details) (Parentheticals) - $ / shares	Jun. 30, 2024	Jun. 30, 2023
Debt with Conversion Feature [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 30	$ 30

Note 5 - Inventories (Details T

Note 5 - Inventories (Details Textual) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Inventory Write-down	$ 0	$ 58

Note 5 - Inventories - Schedule

Note 5 - Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Raw materials	$ 4,426	$ 9,907
Work-in-progress	1,788	1,682
Finished goods	4,030	6,702
Total inventories	$ 10,244	$ 18,291

Note 6 - Property, Plant and _3

Note 6 - Property, Plant and Equipment (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Capitalized Interest Costs, Including Allowance for Funds Used During Construction	$ 1,300	$ 1,000	$ 3,000	$ 2,800
Property, Plant and Equipment, Additions			12,200
Depreciation	$ 2,049	$ 1,671	3,847	$ 3,461
Building [Member] | Keyes Plant [Member]
Property, Plant and Equipment, Disposals			$ 10,000

Note 6 - Property, Plant and _4

Note 6 - Property, Plant and Equipment - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Land	$ 7,345	$ 7,345
Plant and buildings	170,215	136,318
Furniture and fixtures	2,628	2,266
Machinery and equipment	5,628	14,982
Construction in progress	50,538	73,057
Property held for development	15,431	15,431
Finance lease right of use assets	2,889	2,889
Total gross property, plant & equipment	254,674	252,288
Less accumulated depreciation	(60,632)	(57,180)
Total net property, plant & equipment	$ 194,042	$ 195,108

Note 6 - Property, Plant and _5

Note 6 - Property, Plant and Equipment - Depreciation of Property, Plant, and Equipment (Details)	Jun. 30, 2024
Minimum [Member] | Building [Member]
Useful life (Year)	20 years
Minimum [Member] | Machinery and Equipment [Member]
Useful life (Year)	5 years
Minimum [Member] | Furniture and Fixtures [Member]
Useful life (Year)	3 years
Maximum [Member] | Building [Member]
Useful life (Year)	30 years
Maximum [Member] | Machinery and Equipment [Member]
Useful life (Year)	15 years
Maximum [Member] | Furniture and Fixtures [Member]
Useful life (Year)	5 years

Note 7 - Debt (Details Textual)

Note 7 - Debt (Details Textual) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended	6 Months Ended		89 Months Ended
	Jul. 28, 2023	May 16, 2023	Oct. 04, 2022	Mar. 02, 2022	Jul. 06, 2012	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Aug. 01, 2022	Jul. 26, 2022	May 01, 2020	Mar. 06, 2020	Feb. 27, 2019	Jan. 09, 2012
Long-Term Debt						$ 309,016	$ 309,016
Short-Term Debt						$ 18,822	$ 18,822			$ 23,443
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)						$ 11.7	$ 11.7			$ 11.7
Warrants and Rights Outstanding, Term (Year)						5 years 3 months 14 days	5 years 3 months 14 days			5 years 9 months 7 days
Proceeds from Issuance of Debt							$ 8,436	$ 21,627
Debt, Long-Term and Short-Term, Combined Amount						$ 309,016	309,016			$ 294,721
Property, Plant and Equipment, Net						194,042	194,042			195,108
Accounts Payable, Current						28,769	28,769			32,132
Other Long-Term Debt, Noncurrent						51,826	51,826			51,717
AAFK [Member] | Warrants in Connection With Subordinated Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																	$ 0.01
Warrants and Rights Outstanding, Term (Year)																	2 years
Capital Revolving Credit Facility Fuels And Carbon Lines [Member] | GAFI and ACCI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 100,000
Fuels Revolving Line [Member] | GAFI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				50,000
Carbon Revolving Line [Member] | ACCI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 50,000
Third Eye Capital [Member] | Mr. McAfee [Member]
Net Amount at Risk by Product and Guarantee, Net Amount at Risk						10,000	10,000
Third Eye Capital [Member] | Revolving Credit Facility [Member]
Debt Instrument, Face Amount					$ 18,000
Long-Term Debt						27,500	27,500
Debt Issuance Costs, Net						$ 800	$ 800
Debt Instrument, Interest Rate, Stated Percentage						22.25%	22.25%
Third Eye Capital [Member] | Revolving Credit Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					13.75%
Third Eye Capital [Member] | Acquisition Term Notes [Member]
Debt Instrument, Face Amount					$ 15,000
Third Eye Capital [Member] | Revolving Notes Series B [Member]
Long-Term Debt						$ 61,600	$ 61,600
Debt Issuance Costs, Net						600	600
Third Eye Capital [Member] | Revolving Notes Series B [Member] | Prime Rate [Member]
Debt Instrument, Interest Rate, Stated Percentage									22.25%
Debt Instrument, Basis Spread on Variable Rate		13.75%
Term Loan [Member] | Third Eye Capital [Member]
Debt Instrument, Face Amount					7,200
Long-Term Debt						7,200	7,200
Debt Issuance Costs, Net						81	81
Revenue Participation Term Notes [Member] | Third Eye Capital [Member]
Debt Instrument, Face Amount					$ 10,000
Debt Instrument, Interest Rate, Stated Percentage									5%
Revenue Participation Term Notes [Member] | Third Eye Capital [Member] | AAFK [Member]
Long-Term Debt						12,200	12,200
Debt Issuance Costs, Net						$ 128	$ 128
Term Notes [Member] | Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage						14%	14%
Extension Fee						1%
Debt Instrument, Extension Fee, Percentage Payable by Increasing Debt Outstanding						50%
Debt Instrument, Extension Fee, Percentage Payable with Cash						50%
Debt Instrument, Extension Fee, Percentage Payable with Common Stock						110%
Acquisition Term Notes [Member] | Third Eye Capital [Member]
Long-Term Debt						$ 26,900	$ 26,900
Debt Issuance Costs, Net						255	255
Acquisition Term Notes [Member] | Third Eye Capital [Member] | Aemetis Facility Keyes, Inc. [Member]
Debt Instrument, Redemption Fee						7,500	7,500
Acquisition Term Notes [Member] | Third Eye Capital [Member] | Prime Rate [Member]
Debt Instrument, Interest Rate, Stated Percentage									19.25%
Debt Instrument, Basis Spread on Variable Rate					10.75%
Reserve Liquidity Facility [Member] | Third Eye Capital [Member]
Debt Instrument, Face Amount															$ 18,000
Long-Term Debt						0	0
Line of Credit Facility, Maximum Borrowing Capacity															$ 85,000
Debt Instrument, Non-refundable Standby Fee, Percent of Difference Between Principal Amount and the Commitment															2%
Dbet Instrument, Non Refundable One Time Fees															$ 500
Reserve Liquidity Facility Paid Monthly in Arrears [Member] | Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage															30%
Reserve Liquidity Facility if Event of Default Occurred and Continues [Member] | Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage															40%
Fuels Revolving Line [Member] | GAFI [Member]
Debt Instrument, Interest Rate, Stated Percentage				10%
Fuels Revolving Line [Member] | Prime Rate [Member] | GAFI [Member]
Debt Instrument, Basis Spread on Variable Rate				6%
Carbon Revolving Line [Member] | GAFI [Member]
Debt Issuance Costs, Net						1,300	1,300
Short-Term Debt						38,700	38,700
Carbon Revolving Line [Member] | ACCI [Member]
Long-Term Debt						24,900	24,900
Debt Issuance Costs, Net						1,300	1,300
Debt Instrument, Interest Rate, Stated Percentage				8%
Short-Term Debt						800	800
Carbon Revolving Line [Member] | Prime Rate [Member] | ACCI [Member]
Debt Instrument, Basis Spread on Variable Rate				4%
Cilion Shareholder Seller Notes Payable [Member]
Debt Instrument, Face Amount					$ 5,000
Long-Term Debt						7,100	7,100
Debt Instrument, Interest Rate, Stated Percentage					3%
Debt, Long-Term and Short-Term, Combined Amount						7,134	7,134			7,028
Subordinated Notes [Member] | AAFK [Member]
Short-Term Debt						18,500	18,500			17,600
Debt Instrument, Fee Amount																	$ 3,400
Debt Instrument Fee Rate																	10%
Debt Extension Fee, Percentage																	10%
EB5 Phase I Notes [Member]
Long-Term Debt						38,300	38,300			37,900
Debt Instrument, Convertible, Conversion Price (in dollars per share)																$ 30
Proceeds from Issuance of Debt									$ 4,000
EB5 Phase I Notes [Member] | Maximum [Member]
Debt Instrument, Additional Investment Available to Issue									200,000
EB5 Phase I Notes [Member] | Minimum [Member]
Debt Instrument, Investment Raised Per Investor											$ 800			$ 500
EB5 Phase II Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount						4,400	4,400			4,300
Secunderabad Oils [Member]
Debt Instrument, Interest Rate, Stated Percentage													18%
Short-Term Debt						300	300			3,800
Debt Agreement, Maximum Borrowing Capacity													$ 3,600
Leo Edibles & Fats Limited [Member]
Debt Agreement, Maximum Borrowing Capacity												$ 1,270
Construction Loan Agreement [Member]
Long-Term Debt						25,100	25,100			25,100
Debt Instrument, Interest Rate, Stated Percentage			9.25%
Debt, Long-Term and Short-Term, Combined Amount						45,115	45,115			41,024
Debt Agreement, Maximum Borrowing Capacity			$ 25,000
Construction Loan Agreement [Member] | US Treasury (UST) Interest Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			5%
Construction Loan Agreement 2 [Member]
Long-Term Debt						20,800	20,800			16,800
Debt Issuance Costs, Net						800	800			$ 800
Debt Instrument, Interest Rate, Stated Percentage	8.75%
Debt Agreement, Maximum Borrowing Capacity	$ 25,000
Construction Loan Agreement 2 [Member] | US Treasury (UST) Interest Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	5%
Financing Agreement For Capital Expenditures [Member]
Long-Term Debt						3,600	3,600
Short-Term Debt						2,200	2,200
Property, Plant and Equipment, Net						9,600	9,600
Accounts Payable, Current						$ 200	$ 200
Other Long-Term Debt, Noncurrent									$ 3,600

Note 7 - Debt- Schedule of Debt

Note 7 - Debt- Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt, Long-Term and Short-Term, Combined Amount	$ 309,016	$ 294,721
Short-Term Debt	18,822	23,443
Less current portion of debt	74,588	37,028
Total long term debt	234,428	257,693
Third Eye Capital Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	7,156	7,159
Third Eye Capital Revolving Credit Facility [Member]
Debt, Long-Term and Short-Term, Combined Amount	26,677	20,922
Revolving Notes Series B [Member]
Debt, Long-Term and Short-Term, Combined Amount	60,976	54,412
Third Eye Capital Revenue Participation Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	12,024	12,011
Third Eye Capital Acquisition Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	26,672	26,655
Third Eye Capital Fuels Revolving Line [Member]
Debt, Long-Term and Short-Term, Combined Amount	37,376	32,511
Third Eye Capital Carbon Revolving Line [Member]
Debt, Long-Term and Short-Term, Combined Amount	24,381	23,486
Construction Loan Agreement [Member]
Debt, Long-Term and Short-Term, Combined Amount	45,115	41,024
Cilion Shareholder Seller Notes Payable [Member]
Debt, Long-Term and Short-Term, Combined Amount	7,134	7,028
Subordinated Notes 1 [Member]
Short-Term Debt	18,497	17,625
EB-5 Promissory Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	42,665	42,211
Working capital Loan [Member]
Short-Term Debt	316	3,827
Term Loan On Equipment Purchase [Member]
Debt, Long-Term and Short-Term, Combined Amount	$ 27	$ 5,850

Note 7 - Debt - Maturities of L

Note 7 - Debt - Maturities of Long-term Debt (Details) $ in Thousands	Jun. 30, 2024 USD ($)
2025	$ 74,588
2026	180,347
2027	11,151
2028	4,232
2029	1,981
Thereafter	40,671
Total debt	312,970
Debt issuance costs	(3,954)
Total debt, net of debt issuance costs	$ 309,016

Note 8 - Leases (Details Textua

Note 8 - Leases (Details Textual)	3 Months Ended
	Jun. 30, 2024
Minimum [Member]
Lease Term (Year)	1 year
Maximum [Member]
Lease Term (Year)	13 years

Note 8 - Leases - Lease Cost (D

Note 8 - Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating lease expense	$ 196	$ 181	$ 377	$ 362
Short term lease expense	42	21	63	42
Variable lease expense	35	22	67	44
Total operating lease cost	273	224	507	448
Amortization of right-of-use assets	30	30	60	61
Interest on lease liabilities	83	82	169	173
Total finance lease cost	113	112	229	234
Operating cash flows used in operating leases	246	166	414	330
Operating cash flows used in finance leases	83	82	169	173
Financing cash flows used in finance leases	$ 154	$ 228	$ 161	$ 311

Note 8 - Leases - Non-cash Flow

Note 8 - Leases - Non-cash Flow Information Related to ROU Asset and Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Accretion of the lease liability	$ 89	$ 84	$ 164	$ 171
Amortization of right-of-use assets	$ 106	$ 97	$ 211	$ 191
Operating leases (in years) (Year)	6 years 6 months	4 years 8 months 12 days	6 years 6 months	4 years 8 months 12 days
Finance leases (in years) (Year)	12 years 7 months 6 days	13 years 6 months	12 years 7 months 6 days	13 years 6 months
Operating leases	13.70%	14.10%	13.70%	14.10%
Finance leases	13.30%	13.20%	13.30%	13.20%

Note 8 - Leases - Supplemental

Note 8 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Operating lease right-of-use assets	$ 2,195	$ 2,056
Other current liability	475	406
Other long term liabilities	1,813	1,783
Total operating lease liabilities	2,288	2,189
Property and equipment, at cost	2,889	2,889
Accumulated depreciation	(288)	(228)
Property and equipment, net	2,601	2,661
Other current liability	32	30
Other long term liabilities	2,692	2,687
Total finance lease liabilities	$ 2,724	$ 2,717

Note 8 - Leases - Maturities of

Note 8 - Leases - Maturities of Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
2025, Operating leases	$ 787
2025, Finance leases	179
2026, Operating leases	721
2026, Finance leases	151
2027, Operating leases	698
2027, Finance leases	145
2028, Operating leases	661
2028, Finance leases	145
2029, Operating leases	63
2029, Finance leases	145
Thereafter, Operating leases	1,235
Thereafter, Finance leases	9,960
Total lease payments, Operating leases	4,165
Total lease payments, Finance leases	10,725
Less imputed interest, Operating leases	(1,877)
Less imputed interest, Finance leases	(8,001)
Total operating lease liability	2,288	$ 2,189
Total finance lease liability	$ 2,724	$ 2,717

Note 8 - Leases - Lease Income

Note 8 - Leases - Lease Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Lease income	$ 516	$ 484	$ 1,007	$ 953

Note 8 - Leases - Future Minimu

Note 8 - Leases - Future Minimum Lease Payments (Details) $ in Thousands	Jun. 30, 2024 USD ($)
2025	$ 891
2026	805
2027	672
2028	599
2029	617
Thereafter	474
Total future lease commitments	$ 4,058

Note 9 - Aemetis Biogas LLC -_2

Note 9 - Aemetis Biogas LLC - Series A Preferred Financing (Details Textual) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended	44 Months Ended
	Feb. 08, 2024	Dec. 20, 2018	Dec. 31, 2022	Aug. 08, 2022	Jun. 30, 2024	Dec. 31, 2023
Common Units [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)		5,000,000
Preferred Units Series A [Member]
Common Units Authorized (in shares)		11,000,000
Preferred Units, Authorized (in shares)		6,000,000
Preferred Units Series A [Member] | Second Tranche [Member
Preferred Units, Issued (in shares)			6,000,000
Preferred Units Issued Value			$ 30
Stock Redeemed or Called During Period, Shares (in shares)				20,000
Preferred Units Redeemed, Value				$ 0.3
Series A Preferred Stocks [Member]
Common Units Issued (in shares)		6,000,000
Common Units Issuance Value (in dollars per share)		$ 5
PUPA Fifth Amendment [Member]
Preferred Units Issued Value	$ 113
Credit Agreement, Interest Rate	16%
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent					$ 120.5	$ 113.2
PUPA Fifth Amendment [Member] | Prime Rate [Member]
Credit Agreement, Interest Rate	10%

Note 10 - Stock-based Compens_3

Note 10 - Stock-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2016
The 2019 Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)	4,600,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 7.9	$ 7.9
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 9 months 18 days
The 2019 Stock Plan [Member] | Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		363,500	243,850
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 3.1	$ 3.75
Inducement Equity Plan Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				100,000

Note 10 - Stock-based Compens_4

Note 10 - Stock-based Compensation - Schedule of Share-based Payment Award (Details) - The 2019 Stock Plan [Member] - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Balance, Shares Available for Grant (in shares)	456,000
Balance, outstanding (in shares)	5,526,000
Balance, Weighted-Average Exercise Price (in dollars per share)	$ 4.42
Authorized, shares (in shares)	1,740,000
Options Granted, shares (in shares)	(1,761,000)
Options Granted, shares (in shares)	1,761,000
Options Granted, Weighted-Average Exercise Price (in dollars per share)	$ 3.1
Exercised, outstanding (in shares)	(15,000)
Exercised, Weighted-Average Exercise Price (in dollars per share)	$ 2.56
Forfeited/expired, shares available (in shares)	71,000
Forfeited/expired, outstanding (in shares)	(71,000)
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share)	$ 7.39
Balance, Shares Available for Grant (in shares)	142,000
Balance, outstanding (in shares)	7,201,000
Balance, Weighted-Average Exercise Price (in dollars per share)	$ 4.07
Restricted Stock [Member]
RSAs Granted, shares (in shares)	(363,500)	(243,850)

Note 10 - Stock-based Compens_5

Note 10 - Stock-based Compensation - Fair Value Assumptions (Details) - The 2019 Stock Plan [Member] - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Dividend-yield	0%	0%
Risk-free interest rate	4.08%	3.82%
Expected volatility	115.42%	125.32%
Expected life (years) (Year)	5 years 9 months 21 days	7 years
Market value per share on grant date (in dollars per share)	$ 3.1	$ 3.75
Fair value per option on grant date (in dollars per share)	$ 2.65	$ 3.43

Note 11 - Warrants (Details Tex

Note 11 - Warrants (Details Textual) shares in Thousands	3 Months Ended
	Jun. 30, 2024 shares
Class of Warrant or Right, Issued (in shares)	0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	0

Note 11 - Warrants - Schedule o

Note 11 - Warrants - Schedule of Warrants or Rights (Details) - $ / shares shares in Thousands	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Outstanding, warrants (in shares)	530
Outstanding, Weighted - Average Exercise Price (in dollars per share)	$ 11.7
Outstanding, Average Remaining Term in Years (Year)	5 years 3 months 14 days	5 years 9 months 7 days
Granted, warrants (in shares)	113
Granted, Weighted - Average Exercise Price (in dollars per share)	$ 0.01
Exercised, warrants (in shares)	(113)
Exercised, Weighted - Average Exercise Price (in dollars per share)	$ 0.01
Outstanding, warrants (in shares)	530
Outstanding, Weighted - Average Exercise Price (in dollars per share)	$ 11.7

Note 11 - Warrants - Fair Value

Note 11 - Warrants - Fair Value Assumptions (Details)	Jun. 30, 2024 $ / shares yr	Jun. 30, 2023 $ / shares yr
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0	0
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0.0423	0.0376
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	1.0136	1.215
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input | yr	2	5.43
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	0.01	1.53
Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input	5.24	3.14
Fair Value per Warrant on Grant Date [Member]
Warrants and Rights Outstanding, Measurement Input	5.23	2.95

Note 12 - Agreements (Details T

Note 12 - Agreements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Jul. 01, 2022
Marketing Expense	$ 700	$ 200	$ 1,200
Shipping and Handling Costs	800		1,500
Oil and Gas, Result of Operation, Transportation Cost		$ 1,500		$ 2,900
Forward Sales Commitments [Member]
Other Commitment					$ 0
Operating Agreement with Gemini Edibles and Fats India Private Limited [Member]
Debt Agreement, Maximum Borrowing Capacity							$ 12,700
Debt Instrument, Interest Rate, Stated Percentage							18%
Accounts Payable	$ 600		$ 600			$ 7,500

Note 12 - Agreements - Schedule

Note 12 - Agreements - Schedule of Working Capital Agreement Activity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenues	$ 66,561	$ 45,112	$ 139,195	$ 47,263
Accounts payable	28,769		28,769		$ 32,132
J.D. Heiskell [Member]
Accounts receivable	1,322		1,322		1,073
Accounts payable	1,240		1,240		$ 1,207
J.D. Heiskell [Member] | Ethanol Sales [Member]
Revenues	29,437	8,647	54,823	8,647
J.D. Heiskell [Member] | Wet Distiller's Grains Sales [Member]
Revenues	9,302	2,553	18,516	2,553
J.D. Heiskell [Member] | Corn Oil Sales [Member]
Revenues	1,161	89	2,452	125
J.D. Heiskell [Member] | CDS Sales [Member]
Revenues	5	11	26	11
J.D. Heiskell [Member] | Corn Purchases [Member]
Corn purchases	$ 33,407	$ 11,611	$ 64,320	$ 11,913

Note 13 - Segment Information_2

Note 13 - Segment Information (Details Textual) gal in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024 gal	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Number of Reportable Segments	3
California Ethanol [Member]
GallonPerYear (Gallon)	65
California Ethanol [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Ethanol Sales, Wet Distillers Grain and Corn Oil Sales [Member]
Number of Major Customers	1	1	1	1
Concentration Risk, Percentage	95.60%	99%	92.90%	96%
India Biodiesel [Member]
GallonPerYear (Gallon)	60
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Biodiesel Sales [Member] | Customer One [Member]
Concentration Risk, Percentage	44%	49%	42%	47%
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Biodiesel Sales [Member] | Customer Two [Member]
Concentration Risk, Percentage	34%	28%	36%	27%
India Biodiesel [Member] | Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member] | Biodiesel Sales [Member] | Customer Three [Member]
Concentration Risk, Percentage	17%	21%	17%	20%

Note 13 - Segment Information -

Note 13 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues	$ 66,561	$ 45,112	$ 139,195	$ 47,263
Gross profit (loss)	(1,806)	1,956	(2,418)	661
Interest expense including amortization of debt fees	11,724	9,629	22,237	18,676
Accretion and other expenses of Series A preferred units	3,477	6,885	6,788	12,449
Income tax expense	385	1,066	1,263	818
Loss on asset disposals	3,644		3,644	0
Capital expenditures	5,397	2,192	8,980	9,808
Depreciation	2,049	1,671	3,847	3,461
Intersegment Eliminations [Member]
Revenues				0
California Ethanol [Member]
Revenues	40,132	11,332	76,221
Gross profit (loss)	(3,921)	(2,322)	(9,579)	(2,334)
Interest expense including amortization of debt fees	7,919	6,252	14,896	11,770
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense	0		0
Loss on asset disposals	3,644		3,644
Capital expenditures	323	726	430	1,060
Depreciation	1,043	960	2,009	2,069
California Ethanol [Member] | Operating Segments [Member]
Revenues				11,807
California Ethanol [Member] | Intersegment Eliminations [Member]
Revenues				0
California Dairy Renewable Natural Gas [Member]
Revenues	1,598	210	5,390
Gross profit (loss)	(136)	(1,064)	2,074	(1,837)
Interest expense including amortization of debt fees	730	517	1,366	1,221
Accretion and other expenses of Series A preferred units	3,477	6,885	6,788	12,449
Income tax expense	2		36
Loss on asset disposals	0		0
Capital expenditures	4,306	1,304	7,149	7,803
Depreciation	771	523	1,340	980
California Dairy Renewable Natural Gas [Member] | Operating Segments [Member]
Revenues				416
California Dairy Renewable Natural Gas [Member] | Intersegment Eliminations [Member]
Revenues				0
India Biodiesel [Member]
Revenues	24,831	33,570	57,584
Gross profit (loss)	2,251	5,342	5,087	4,832
Interest expense including amortization of debt fees	204	225	629	294
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense	383		1,227
Loss on asset disposals	0		0
Capital expenditures	14	115	318	151
Depreciation	180	157	388	312
India Biodiesel [Member] | Operating Segments [Member]
Revenues				35,040
India Biodiesel [Member] | Intersegment Eliminations [Member]
Revenues				0
Other Operating Segment [Member]
Revenues	0	0	0
Gross profit (loss)	0	0	0	0
Interest expense including amortization of debt fees	2,871	2,635	5,346	5,391
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense	0		0
Loss on asset disposals	0		0
Capital expenditures	754	47	1,083	794
Depreciation	$ 55	$ 31	$ 110	100
Other Operating Segment [Member] | Operating Segments [Member]
Revenues				0
Other Operating Segment [Member] | Intersegment Eliminations [Member]
Revenues				$ 0

Note 13 - Segment Information_3

Note 13 - Segment Information - Reconciliation of Assets from Segments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets	$ 232,088	$ 243,406
California Ethanol [Member]
Assets	58,966	67,991
California Dairy Renewable Natural Gas [Member]
Assets	105,664	92,794
India Biodiesel [Member]
Assets	26,547	34,769
Other Operating Segment [Member]
Assets	$ 40,911	$ 47,852

Note 14 - Related Party Trans_2

Note 14 - Related Party Transactions (Details Textual) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024
Various Board Members [Member]
Share-Based Payment Arrangement, Expense	$ 0.1	$ 0.2
Employment Agreements and Expense Reimbursements [Member] | Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction	0.9
Board Compensation Fees [Member] | Various Board Members [Member]
Related Party Transaction, Amounts of Transaction	$ 0.3

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Jul. 31, 2024	Jul. 01, 2024	Jun. 30, 2024	Dec. 31, 2023	Jan. 09, 2012
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			0
Warrants and Rights Outstanding, Term (Year)			5 years 3 months 14 days	5 years 9 months 7 days
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)			$ 11.7	$ 11.7
Subsequent Event [Member] | PUPA Sixth Amendment [Member]
Preferred Units Issued Value	$ 113,000
AAFK [Member] | Warrants in Connection With Subordinated Notes [Member]
Warrants and Rights Outstanding, Term (Year)					2 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 0.01
AAFK [Member] | Subsequent Event [Member] | Warrants in Connection With Subordinated Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		113
Warrants and Rights Outstanding, Term (Year)		2 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.01
Subordinated Notes 1 [Member] | AAFK [Member] | Subsequent Event [Member]
Debt Instrument, Cash Extension Fee		$ 90
Subordinated Notes 2 [Member] | AAFK [Member] | Subsequent Event [Member]
Debt Instrument, Cash Extension Fee		$ 250